Stay updated on Influenza Vaccine Reactogenicity in Younger and Older Adults Clinical Trial
Sign up to get notified when there's something new on the Influenza Vaccine Reactogenicity in Younger and Older Adults Clinical Trial page.

Latest updates to the Influenza Vaccine Reactogenicity in Younger and Older Adults Clinical Trial page
- Check6 days agoChange DetectedLocations section updated to include Nova Scotia and Quebec as study sites, with corresponding Nova Scotia and Quebec Location blocks removed. Page revision updated from v3.3.2 to v3.3.3, and the HHS Vulnerability Disclosure link was removed from the footer.SummaryDifference0.3%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedRevision update from v3.2.0 to v3.3.2 is reflected on the page; this is a minor versioning change and does not modify study content, eligibility criteria, or displayed information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedRemoved the general government funding status notice about NIH operations. This change does not affect the study details, eligibility criteria, endpoints, or site locations listed on the page.SummaryDifference0.3%

- Check57 days agoChange DetectedAdded an IPD sharing plan with access criteria and timeline. Updated the study record to include IPD-related information and related documents.SummaryDifference0.4%

- Check85 days agoChange DetectedThe page updates to v3.2.0, now shows 'Results Submitted' instead of 'No Results Posted', and adds operating-status notices for NIH-related entities.SummaryDifference2%

- Check92 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release revision but no evident substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Influenza Vaccine Reactogenicity in Younger and Older Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Influenza Vaccine Reactogenicity in Younger and Older Adults Clinical Trial page.